| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |